AcelRX Pharmaceuticals 뉴스 - ACRX

기업명	주식 심볼	시장	주식 타입
AcelRX Pharmaceuticals Inc	ACRX	나스닥	보통주

	가격 변동	가격 변동 %	주식 가격	최근 거래 시간
	0.00	0.00%	0.86	09:00:00

개장가	저가	고가	종가	전일 종가
				0.86

시세 정보 더보기 »

최근 뉴스

일자	시간	출처	제목
20/04/2024	05:37	EDGAR2	Form 8-K - Current report
22/03/2024	05:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
16/03/2024	05:01	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
13/03/2024	07:39	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
09/01/2024	23:17	EDGAR2	Form 8-K - Current report
09/01/2024	23:05	PRNUS	AcelRx Announces Rebranding With Name Change to Talphera,..
14/12/2023	22:11	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
14/12/2023	06:34	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
14/12/2023	06:25	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/12/2023	22:30	PRNUS	AcelRx Pharmaceuticals Announces Publication of Study..
01/12/2023	14:15	EDGAR2	Form EFFECT - Notice of Effectiveness
23/11/2023	06:38	EDGAR2	Form S-3 - Registration statement under Securities Act of..
23/11/2023	06:34	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
14/11/2023	20:07	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/2023	06:14	EDGAR2	Form 8-K - Current report
09/11/2023	06:05	PRNUS	AcelRx Reports Third Quarter 2023 Financial Results and..
08/11/2023	06:05	PRNUS	AcelRx to Host KOL Panel Discussion on Current Anticoagulant..
27/10/2023	05:30	PRNUS	AcelRx to Host Third Quarter 2023 Financial Results Call and..
21/10/2023	05:30	EDGAR2	Form 8-K - Current report
11/10/2023	05:17	EDGAR2	Form 8-K - Current report
06/10/2023	05:45	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
06/10/2023	05:30	EDGAR2	Form 8-K - Current report
03/10/2023	21:30	PRNUS	AcelRx Receives IDE Approval for Niyad and Advances to a..
23/09/2023	06:18	EDGAR2	Form 8-K - Current report
12/09/2023	08:13	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
06/09/2023	21:30	PRNUS	AcelRx Pharmaceuticals to Participate in the H.C. Wainwright..
28/08/2023	19:35	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
28/08/2023	19:34	EDGAR2	Form DEF 14A - Other definitive proxy statements
26/08/2023	05:45	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
26/08/2023	01:45	EDGAR2	Form 144 - Report of proposed sale of securities
25/08/2023	05:23	EDGAR2	Form 144 - Report of proposed sale of securities
11/08/2023	06:00	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/08/2023	05:10	EDGAR2	Form 8-K - Current report
11/08/2023	05:05	PRNUS	AcelRx Reports Second Quarter 2023 Financial Results and..
10/08/2023	06:29	EDGAR2	Form 424B7 - Prospectus [Rule 424(b)(7)]
02/08/2023	19:06	EDGAR2	Form S-3 - Registration statement under Securities Act of..
28/07/2023	05:05	PRNUS	AcelRx to Host Second Quarter 2023 Financial Results Call..
21/07/2023	21:15	EDGAR2	Form 8-K - Current report
21/07/2023	21:00	PRNUS	AcelRx Pharmaceuticals Announces Closing of Previously..
18/07/2023	21:00	PRNUS	AcelRx Pharmaceuticals Announces $10 Million Private..
11/05/2023	05:05	PRNUS	AcelRx Pharmaceuticals Reports First Quarter 2023 Financial..

이 » 주식의 기사 더보기;

시장 데이터

뉴스

도구

시장

팔로우

Hot Features

피드 팔로우

실시간 옵션 플로우

모니터

ACRX AcelRX Pharmaceuticals Inc

최근 뉴스

ACRX 과거 데이터 - 1일

ACRX 과거 데이터 - 1년

최근 히스토리

회사 소개

사업

Popular

앱 받기

시장 데이터

뉴스

도구

시장

팔로우

Hot Features

피드 팔로우

실시간 옵션 플로우

모니터

AcelRX Pharmaceuticals Inc (ACRX) 뉴스

ACRX AcelRX Pharmaceuticals Inc

최근 뉴스

ACRX 과거 데이터 - 1일

ACRX 과거 데이터 - 1년

최근 히스토리

회사 소개

사업

Popular

앱 받기